Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass

Altimmune’s investigational obesity treatment pemvidutide preserved lean muscle mass while inducing weight loss in adults with obesity, with the majority of the drop in body weight from fat, according to a data readout of the Phase II MOMENTUM study unveiled on Sunday.